In the published article, there was an error in Figure 3 as published. Due to the large number of photos taken, careless naming errors led to the accidental reuse of some images. The corrected Figure 3 and its caption Figure 3. Effects of PYR and ADM on cell invasion appear below.
Figure 3
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
HER2 positive breast neoplasm, pyrotinib, adriamycin, synergistic, Akt
Citation
Wang C, Deng S, Chen J, Xu X, Hu X, Kong D, Liang G, Yuan X, Li Y and Wang X (2025) Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer. Front. Oncol. 15:1536374. doi: 10.3389/fonc.2025.1536374
Received
28 November 2024
Accepted
07 February 2025
Published
18 March 2025
Volume
15 - 2025
Edited and reviewed by
Sharon R. Pine, University of Colorado Anschutz Medical Campus, United States
Updates
Copyright
© 2025 Wang, Deng, Chen, Xu, Hu, Kong, Liang, Yuan, Li and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinshuai Wang, xshuaiw@haust.edu.cn; Yuanpei Li, lypli@ucdavis.edu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.